EP0764644A1 — Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition
Assigned to GD Searle LLC · Expires 1997-03-26 · 29y expired
What this patent protects
A class of 3,4-diaryl substituted furan derivatives and analogs thereof, and their use for preparing a medicament for treating a gastrointestinal condition. Compounds of particular interest are defined by a formula selected from wherein X is hydrogen or hydroxy; wherein R 2…
USPTO Abstract
A class of 3,4-diaryl substituted furan derivatives and analogs thereof, and their use for preparing a medicament for treating a gastrointestinal condition. Compounds of particular interest are defined by a formula selected from wherein X is hydrogen or hydroxy; wherein R 2 is aryl optionally substituted with a radical selected from halo, lower alkoxy, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, nitro, amino, sulfamyl and lower alkylsulfonylamino; and wherein R 3 is aryl optionally substituted with a radical selected from halo, lower alkoxy, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, nitro, amino, lower alkylamino, lower alkylsulfonylamino and sulfamyl; provided that at least one of R 2 and R 3 is substituted with methylsulfonyl or sulfamyl; or a pharmaceutically-acceptable salt thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.